Class II · Moderate risk Ongoing
Thyroid
Reason Subpotent Drug
Natpara
Class I — High risk. Reasonable probability of serious harm or death.
Why it was recalled
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
What was recalled
Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0202-02
- Recalling firm
- Shire Human Genetic Therapies, Inc.
- NDC code
- 68875-0202-02
- Origin
- MA, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0035-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Thyroid recalls
See all
Class II · Moderate risk Completed
S.P Labs
Reason Failed Stability Specifications
Class II · Moderate risk Completed
S.P.Labs
Reason Failed Stability Specifications
Class II · Moderate risk Terminated
Levothyroxine 25mcg in Ns 1.25ml Syringe
Reason Lack of sterility assurance
Class II · Moderate risk Terminated
Armour Thyroid
Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.